167
Financial Information and Risk
Management
İş Bankası
Annual Report 2013
TÜRKİYE İŞ BANKASI A.Ş.
Notes to the Unconsolidated Financial Statements
for the Year Ended 31 December 2013
j.3. Financial statement information related to subsidiaries in the above order
(1)
:
No
Total Assets
Shareholders’
Equity
Total
Tangible
Assets
Interest
Income
(2)
Securities
Income
Current
Period
Profit/Loss
Prior Period
Profit/Loss Fair Value
Additional
Shareholders’
Equity
Required
1-
7,908,679
540,143 26,684 232,141
33,851 84,706
80,952 1,841,000
2-
48,286
23,189 8,283
2
-5,582
-3,803
3-
119,056
119,050
2 29,662 27,855
18,995
4-
483,610
103,625 47,921 29,518
185 -16,040
-2,479
5-
3,492,581
603,638 2,958 188,495
2,573 42,189
41,801 407,390
6-
1,668,720 1,156,086 1,379,950 5,630
1,109 116,157
65,408 882,000
7-
39,854
15,814
1,185 1,881
335
6,083
6,053
8-
42,686
34,577 16,846
195
408 3,108
11,620
9-
4,935,366
917,423 95,408 194,142 139,022 125,312 137,364 397,440
10-
2,643,785
378,985 52,444 100,712
3,001
2,476
15,188
11-
14,479
9,131
713
1
20 1,452
1,701
12-
1,847,224
702,006 43,700 65,176 20,412 22,639 98,349
13-
604,079
480,807 190,524
580 281,101 253,150 -19,383
14-
436,842
436,839
237
218
57
15-
13,439,216 2,017,534 248,941 657,490 23,443 295,154 325,151 2,379,000
16- 10,946,553 6,312,906 5,705,274 35,448
47 268,198 290,393 4,273,120
(1)
Indicates financial data of Anadolu Hayat Emeklilik A.Ş., Closed Joint Stock Company İşbank, İş Finansal Kiralama A.Ş., İş Gayrimenkul Yatırım Ortaklığı A.Ş., İş Yatırım
Menkul Değerler A.Ş., İşbank AG, Milli Reasürans T.A.Ş., Türkiye Sınai Kalkınma Bankası A.Ş. are as at 31 December 2013; Türkiye Şişe ve Cam Fabrikaları A.Ş. are as at 30
September 2013; and the financial data of other companies are as of 31 December 2012.
(2)
Includes interest income on securities.
j.4. Movement of investments in subsidiaries:
Current Period
Prior Period
Balance at the Beginning of the Period
6,956,039
5,531,102
Movements in the Period
Purchases
(1)
336,771
369,313
Bonus Shares Acquired
Dividends Received from Current Year Profit
Sales
(2)
(269,593)
Revaluation Surplus
(3)
(107,746)
997,530
Impairment
101,385
58,094
Balance at the End of the Period
7,016,856
6,956,039
Capital Commitments
Contribution in equity at the end of the period (%)
(1)
Due to various subsidiaries’ capital increase through issuance of bonus shares in the current period
(2)
The amount is comprised of the sales of Bayek Tedavi Sağlık Hizmetleri ve İşletmeciliği A.Ş. ve Mipaş Mümessillik İthalat İhracat ve Pazarlama A.Ş.
(3)
The relevant amounts represent the increases and decreases in the market value of participations traded on the stock exchange.
